2 Results for "

BPRMU191

" in MedChemExpress (MCE) Product Catalog:
Products (2)

2 Results for "BPRMU191" in MCE Product Catalog:

Cat. No.: HY-159923
CAS No.: 2131199-52-3
Target:  

Opioid Receptor

Research Areas:  

Neurological Disease

BPRMU191 is a μ-opioid receptor (MOR) modulator that converts small-molecule morphinan antagonists into G protein-biased MOR agonists, thereby inducing MOR-dependent activation and analgesic effects. Co-administration of BPRMU191 with morphinan antagonists provides analgesia while reducing side effects such as gastrointestinal dysfunction, antinociceptive tolerance, and dependency-related adverse effects. BPRMU191, in combination with morphinan antagonists, offers a potential strategy for studying severe pain management and G protein-coupled receptor modulation .
loading...
    loading...
Cat. No.: HY-159924
CAS No.: 2131200-75-2
Target:  

Opioid Receptor

Research Areas:  

Neurological Disease

DBPR116 is a prodrug of BPRMU191 (HY-159923) with blood-brain barrier penetration capability. DBPR116 significantly improves the delivery of centrally targeted drugs. In combination with the antagonist Naltrexone (HY-76711), DBPR116 demonstrated superior safety and analgesic efficacy compared to morphine in various in vivo pharmacological studies, including thermal pain models, cancer pain models, constipation, sedation, psychological dependence, heart rate, and respiratory frequency. As a prodrug strategy for peripheral administration, DBPR116 effectively alleviates pain while reducing adverse effects, showing potential as a safer opioid analgesic .
loading...
    loading...